Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eisenberg Paris is a luxury French skincare, fragrance, and cosmetics brand founded by José Eisenberg in 2000. The company is built upon the proprietary Trio-Molecular Formula, a patented technology developed after 15 years of research that combines enzymes, cytokines, and biostimulins to regenerate, energize, and oxygenate the skin. Their product portfolio includes high-end anti-aging treatments, sun care, and professional-grade makeup, primarily distributed through selective retail channels and luxury boutiques. The brand emphasizes the intersection of science, art, and nature, positioning itself in the cosmeceutical space with a focus on cellular-level skin health. Eisenberg Paris remains a family-owned business with a significant global presence in Europe, Asia, and the Middle East.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eisenberg Paris.